Assignee
ObsEva SA
CH15 patents
Top patents by PatentIndex Score
US9670155B2Jun 6, 2017
Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
ObsEva SA12 citations89
US9962367B2May 8, 2018
Oral formulations of pyrrolidine derivatives
ObsEva SA5 citations80
US10555934B2Feb 11, 2020
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
ObsEva SA4 citations71
US10604482B2Mar 31, 2020
Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists
ObsEva SA2 citations70
US10047048B2Aug 14, 2018
Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
ObsEva SA3 citations70
US11419851B2Aug 23, 2022
Oral formulations of pyrrolidine derivatives
ObsEva SA1 citations69
US10478420B2Nov 19, 2019
Oral formulations of pyrrolidine derivatives
ObsEva SA3 citations69
US12280052B2Apr 22, 2025
Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis
ObsEva SA0 citations61
US11980621B2May 14, 2024
Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis
ObsEva SA1 citations61
US11524003B2Dec 13, 2022
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
ObsEva SA0 citations61
US9718772B2Aug 1, 2017
Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same
ObsEva SA3 citations61
US11759464B2Sep 19, 2023
Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss
ObsEva SA1 citations60
US11534428B1Dec 27, 2022
Compositions and methods for delaying the incidence of labor
ObsEva SA0 citations60
US11312683B2Apr 26, 2022
Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists
ObsEva SA0 citations59
US10752583B2Aug 25, 2020
Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same
ObsEva SA0 citations40